LY3819253 (LY-CoV555)

LY-CoV555 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3819253 (LY-CoV555), covering 2021-12-06 to 2021-12-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3819253 (LY-CoV555) in Healthy Participants [Phase 1]